1035229-33-4 Usage
Description
5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one is a white to off-white solid chemical compound that belongs to the oxazinone class. It is soluble in organic solvents and features a unique structure with 2-chloroacetyl and benzyloxy functional groups, making it a versatile building block for the synthesis of diverse chemical structures.
Uses
Used in Pharmaceutical Research and Development:
5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one is used as a building block for the synthesis of various types of compounds in the pharmaceutical industry. Its unique structure and properties make it an important intermediate in the development of new drugs for the treatment of various diseases.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one is utilized for the development of bioactive compounds. Its functional groups allow for the construction of diverse chemical structures, contributing to the advancement of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1035229-33-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,2,2 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1035229-33:
(9*1)+(8*0)+(7*3)+(6*5)+(5*2)+(4*2)+(3*9)+(2*3)+(1*3)=114
114 % 10 = 4
So 1035229-33-4 is a valid CAS Registry Number.
1035229-33-4Relevant articles and documents
SMYD2 INHIBITORS
-
, (2016/02/20)
The present disclosure generally relates to compounds having cellular anti-proliferative activities, and more particularly relates to compounds which inhibit the activity of human SMYD2, a SET and MYND domain-containing protein lysine methyltransferase.
NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS USEFUL AS BIFUNCTIONAL MODULATORS OF M3 RECEPTORS AND BETA-2 RECEPTORS
-
Page/Page column 49-50, (2010/04/03)
The present invention relates to named compounds of the formula (I) having both M3 receptor antagonist and β2 agonist activity; compositions comprising such compounds; the use of such compounds in therapy (such as respiratory tract disorders); and a metho
BICYCLOR [2.2.1] HEPT-7-YLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES AND CONDITIONS IN WHICH M3 MUSCARINIC RECEPTOR ACTIVITY AND BETA-ADRENERGIC ACTIVITY ARE IMPLICATED
-
, (2009/01/24)
The present invention relates to compounds of formula (I) having muscarinic M3 receptor and β-adrenergic receptor modulating activity; wherein R1, R2, R3 and X are as defined herein.